{"DataElement":{"publicId":"6133604","version":"1","preferredName":"Rhabdomyosarcoma Children's Oncology Group Risk Assessment Category","preferredDefinition":"Text term used to describe the classification of rhabdomyosarcoma, as defined by the Children's Oncology Group (COG).","longName":"cog_rhabdomyosarcoma_risk_grou","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"6133487","version":"1","preferredName":"Rhabdomyosarcoma Children's Oncology Group Risk Assessment","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites._An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers._An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","longName":"5133371v1.0:3521409v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"5133371","version":"1","preferredName":"Rhabdomyosarcoma","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.","longName":"C3359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyosarcoma","conceptCode":"C3359","definition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C8D7F04-85B5-6F2F-E050-BB89AD4335F7","latestVersionIndicator":"Yes","beginDate":"2016-02-24","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-02-24","modifiedBy":"ONEDATA","dateModified":"2016-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3521409","version":"1","preferredName":"Children's Oncology Group Risk Assessment","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.:The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.","longName":"C39353:C15367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Health Risk Assessment","conceptCode":"C15367","definition":"An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4695DE6-BCA8-D5C8-E040-BB89AD430E9C","latestVersionIndicator":"Yes","beginDate":"2012-07-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-09","modifiedBy":"ONEDATA","dateModified":"2012-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6761B428-6D21-3B88-E053-F662850AAA0A","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"COOPERM","dateModified":"2020-08-17","changeDescription":"Created for caDSR Requests Q12018 Dictionary Updates for Review 3.8.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6133520","version":"1","preferredName":"COG Risk Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"6133520v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High Risk","valueDescription":"High risk","ValueMeaning":{"publicId":"2580324","version":"1","preferredName":"High risk","longName":"2580324","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Risk","conceptCode":"C102401","definition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-06D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-07-27","modifiedBy":"SHIDED","dateModified":"2013-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6761AD03-D266-3644-E053-F662850AD35A","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"},{"value":"Intermediate Risk","valueDescription":"Intermediate Risk","ValueMeaning":{"publicId":"4903637","version":"1","preferredName":"Intermediate Risk","longName":"4903637","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is moderate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Risk","conceptCode":"C102402","definition":"The potential future harm that may arise from some present action or attribute or condition is moderate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B153AB5-0BD7-4322-E050-BB89AD433CC8","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6761AD03-D271-3644-E053-F662850AD35A","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"},{"value":"Low Risk","valueDescription":"Low risk","ValueMeaning":{"publicId":"2576351","version":"1","preferredName":"Low risk","longName":"2576351","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is small.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Risk","conceptCode":"C102403","definition":"The potential future harm that may arise from some present action or attribute or condition is small.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F74C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-29","modifiedBy":"SHIDED","dateModified":"2013-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6761AD03-D27B-3644-E053-F662850AD35A","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6761AD03-D286-3644-E053-F662850AD35A","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6761AD03-D291-3644-E053-F662850AD35A","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"ONEDATA","dateModified":"2018-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6761AD03-D24E-3644-E053-F662850AD35A","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"COLBERTM","dateModified":"2020-08-21","changeDescription":"Created for caDSR Requests Q12018 Dictionary Updates for Review 3.8.18 mc   Confirmed list and released VD after verification of the property in the GDC data dictionary. 8/21/20 MRC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"COG Risk Group","type":"Preferred Question Text","description":"COG Risk Group","url":null,"context":"GDC"}],"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6761AD03-D345-3644-E053-F662850AD35A","latestVersionIndicator":"Yes","beginDate":"2018-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-14","modifiedBy":"COLBERTM","dateModified":"2020-08-21","changeDescription":"Created for caDSR Requests Q12018 Dictionary Updates for Review 3.8.18 mc   Released DE after verification of the property in the GDC data dictionary. 8/21/20 MRC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}